Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Petauri and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR

Petauri

Nashville, Tennessee, USA
VISIT WEBSITE
Petauri is a purpose-built pharmaceutical commercialization services platform designed to support life sciences companies throughout the therapeutic life cycle, from discovery to post-launch. The company focuses on establishing the clinical, economic, humanistic, and societal value of medical advances to ensure that scientific breakthroughs reach patients with unmet medical needs. Formed in partnership with private equity firm Oak Hill Capital, Petauri operates as an integrated platform that has scaled through the strategic acquisition and rebranding of various best-in-class agencies. Its service offerings are organized into business units including Petauri Advance (medical and scientific communications), Petauri Advisors (pricing and access consulting), Petauri Evidence (HEOR), Petauri MAx (market access marketing), Petauri Kinect (health system engagement), and Artia Solutions.
CLASSIFICATION
Company Type:CRO
Therapeutic Areas:
Industry:Pharmaceuticals
Sub-Industry:Pharmaceutical Commercialization Services
SIZE & FINANCIALS
Employees:201-500
Founded:2023
Ownership:private
Status:operating
FUNDING
Stage:Private Equity Backed
Total Raised:$250M+
Investors:Oak Hill Capital
0
CORPORATE STRUCTURE
Subsidiaries:The Kinetix Group, FORCE Communications, Mtech Access, Delta Hat, Artia Solutions, Formulary Insights
Key Partnerships:Supports 23 of the top 25 pharmaceutical companies
COMPETITION
Position:Challenger
Competitors:McKinsey, Deloitte, Gallagher, Avalere Health
LEADERSHIP
Key Executives:
Dan Renick - CEO
Dan Vanderpoel - Executive VP
Board Members:Dan Renick
LINKS
Website:petauri.com
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Petauri. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.